Ablynx is a startup based in Belgium, most recent round Acquired, 3 tracked investors.
Ablynx is a company headquartered in Belgium. Ablynx has been acquired. Brouky records 3 investors associated with the company.
Ablynx is a biopharmaceutical company specializing in the discovery and development of nanobodies, a class of proprietary therapeutic proteins designed to treat serious human diseases including inflammation, haematology, immuno-oncology, oncology, and respiratory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.